Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Payables-Turnover" stands at 4.57 as of 09/30/2025, the lowest value since 03/31/2024.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Payables Turnover" stands at 4.57. This represents a decrease of -2.73 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -11.09 percent compared to the value the year prior.
The 1 year change in percent is -11.09.
The 3 year change in percent is -12.15.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Payables Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Payables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Payables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Payables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Payables Turnover | 280,205,508,085.11 |